Cabergoline, a dopamine agonist, is a medication used primarily to treat disorders resulting from excess levels of the hormone prolactin. Its pharmacological action is recognized for effective suppression of prolactin secretion, leading to various therapeutic applications.
You can find detailed information about Cabergoline’s effectiveness and usage in this resource.
Cabergoline acts specifically on dopamine D2 receptors, mimicking the action of dopamine in the brain. It effectively reduces elevated prolactin levels by:
Some of the clinical applications of Cabergoline include:
While Cabergoline is generally well-tolerated, some individuals may experience side effects such as:
Cabergoline by Astera Labs presents a reliable pharmacological option for managing elevated prolactin levels. Its mechanism of action enables effective treatment of related disorders, although it is essential to monitor potential side effects during treatment.